Navigation Links
Celsense, Inc Files FDA & EMEA Regulatory Submissions
Date:10/12/2009

Click( this.href );" target="_blank" title="Cell Sense in clinical use">Cell Sense in clinical use.

“Several customers are now planning to incorporate the use of Cell Sense in new and existing INDs,” stated O’Hanlon, “and having a DMF/ASMF for them to reference will encourage product adoption, shorten the qualification process for customers, and meet our corporate goal of having the first imaging reagent formally approved for non-invasive, human clinical in vivo tracking of therapeutic and diagnostic cells.”

In October 2007, the U.S. FDA concluded, in response to the company’s request for designation, that Cell Sense is a drug that will be reviewed and regulated by the Center for Biologics Evaluation and Research (CBER) under the new drug provisions of the Federal Food, Drug, and Cosmetic Act (the Act).

Cell Sense is a fluorocarbon ex vivo cell label that enables investigators and clinicians the ability to non-invasively track the therapeutic and diagnostic cells in vivo using Magnetic Resonance Imaging (MRI). The emulsion is a self-delivering nanoparticle that requires no exogenous transfection agent and is stable at lysosomal pH levels within the cell. Cell Sense emulsion enables investigators the ability to identify, quantify, and follow pre-labeled cells in vivo using fluorine (19F) magnetic resonance imaging (MRI) technologies.

Celsense, Inc. has three reagents for MRI imaging of cells currently on the market for pre-clinical research and discovery. The company also offers Voxel Tracker workstation software that maximizes the Cell Sense MRI data set. Customers include leading pharmaceutical and biotechnology companies and medical research centers worldwide.

About Cell Sense
Cell Sense is a fluorocarbon tracer agent used to
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Pan-American Life Insurance Group Plans to Complete Coverage in Central America With Entry Into Costa Rica; Company Files Request for Authorization
2. Profiles International Finds High Employee Utilization is One Key to Maximizing Productivity
3. Reportlinker Adds H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) Report
4. Texas Doctor Files Case Pro Se in U.S. Supreme Court Against Insurance Giant on Integrity and Unethical Practices
5. Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders & Financiers at AdvaMed 2009
6. Warner Chilcott Files New Lawsuit for Infringement of LOESTRIN(R) 24 FE and FEMCON(R) FE Patents
7. GENova files patent for new breast cancer treatment
8. Longevinex(R) Files Lawsuit Against ResveratrolBenefits.com, for False and Misleading Statements
9. US Farms, Inc. Files Trademark Application for Aloe365
10. Genova files patent for new prostate cancer treatment
11. Sun Pharmaceutical Files HSR Application for Taro Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Celsense, Inc Files FDA & EMEA Regulatory Submissions
(Date:12/25/2014)... December 26, 2014 The report ... to 2023” focuses on the current treatment landscape, ... the colorectal cancer market. Stivarga is a drug ... or rectal cancer. Boehringer Ingelheim is developing nintedanib ... treatment of refractory CRC in the US, Europe, ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) ... LLP reports. According to an Order issued in the ... 20th, the Court will convene an open conference on ... Building and United States Courthouse in West Palm Beach, ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of wedding dresses and ... of black one-shoulder cocktail dresses . In addition, all ... at discounted prices, up to 70% off. , ... weeks only. You know, we have thousands of frequent callers ... new items can visit our website for more details. The ...
Breaking Medicine News(10 mins):Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2
... MIAMI , Feb. 12 Flowers? Check.  Chocolates?  Check. ... Valentine,s Day with the one you love, don,t let condom ...  Sensis makes applying a condom a more passionate part of the ... to help people practice safer sex while preserving the passion and ...
... Mich. , Feb. 12 Perrigo Company (Nasdaq: ... has granted summary judgment in its favor in patent litigation ... Mucinex® tablets. Perrigo had been sued by Adams Respiratory Therapeutics, ... Drug Application holder and patent owner. The United States District ...
... LAVAL , Québec and PRINCETON, NJ , Feb. 12 ... that it has priced an underwritten public offering of 11,764,706 newly issued ... Each unit is comprised of one of the Company,s common shares and ... entitles the holder to acquire one common share of the Company upon ...
... ... of First Lady Michelle Obama’s "Let’s Move" initiative and praised the First Lady for ... the health of America’s children and the future of our country. , ... (PRWEB) February 12, 2010 -- ...
... reopen clogged coronary artery , THURSDAY, Feb. 11 (HealthDay ... be "in good spirits" Thursday evening in a New ... into a clogged heart artery. , The 63-year-old Clinton, ... complaining of chest pains. , "Today President Bill Clinton ...
... ... high protein (35.7% per serving), zero cholesterol and zero trans fats with a good source ... diabetic, and the weight conscious. , ... Clara City, MN (PRWEB) February 10, 2010 -- With all this talk about obesity, ...
Cached Medicine News:Health News:Sensis Condoms With QuikStrips(TM) Reminds Lovers To Protect The Passion This Valentine's Day 2Health News:Sensis Condoms With QuikStrips(TM) Reminds Lovers To Protect The Passion This Valentine's Day 3Health News:Perrigo Granted Summary Judgment of Non-Infringement in Mucinex(R) Case 2Health News:Perrigo Granted Summary Judgment of Non-Infringement in Mucinex(R) Case 3Health News:Labopharm announces pricing of US$20 million public offering of units 2Health News:Labopharm announces pricing of US$20 million public offering of units 3Health News:Labopharm announces pricing of US$20 million public offering of units 4Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 2Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 3Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 4Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 5Health News:IHRSA Heartily Applauds First Lady's "Let's Move" Initiative and Vows Support 6Health News:Ex-President Clinton Said To Be Fine After Heart Procedure 2Health News:Ex-President Clinton Said To Be Fine After Heart Procedure 3Health News:New and Delicious, Almond Butter Filled, Cookie Bites With 35.7% Protein to Help Manage Weight and Build Muscle 2
(Date:12/24/2014)... , Dec. 24, 2014  Actavis plc (NYSE: ... Company has received a complete response letter from ... its New Drug Application (NDA) for the fixed-dose ... treatment of hypertension.   Photo - ... disappointed in the receipt of a complete response ...
(Date:12/24/2014)... 24, 2014 Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today that on December 24, 2014 it closed ... The Company raised approximately $2.3 million in gross ... the net proceeds from the offering to fund ...
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 ... a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ... medical need and commercial potential, today announced that ... 2,050,000 shares of its common stock and Series ... common stock.  Funds under the management of QVT ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4
This model of bench top refrigerated incubator has been designed to suit the TPS-32 platelet shaker....
ELISA for detection of Anti-Gliadin IgG....
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Enzyme immunoassay for the quantitative determination of Gliadin-IgG antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
Medicine Products: